National Heart, Lung, and Blood Institute; Amended Notice of Meeting, 69137 [06-9457]
Download as PDF
<![CDATA[
Federal Register / Vol. 71, No. 229 / Wednesday, November 29, 2006 / Notices
jlentini on PROD1PC65 with NOTICES
Central Mid-Atlantic Division (RCP)
Manages BPHC primary health care
grant programs and activities within
HHS Regions 3, 5 and 6. Specifically, for
regions 3, 5 and 6: (1) Manages the postaward administration of the Bureau’s
primary health care grant programs; (2)
serves as the BPHC representative to
organizations receiving Bureau grants;
(3) promotes a continued focus on
efficient and effective care for
underserved and vulnerable
populations; (4) communicates and
interprets program statutory/regulatory
requirements, policy, expectations and
reporting requirements, providing
technical guidance to grantees on the
management and integration of
community-based systems of care, the
adaptation of successful strategies/
models, and the resolution of difficult
issues; (5) monitors the performance of
BPHC primary health care grantees,
making programmatic recommendations
and providing assistance to improve
performance, where appropriate; (6)
reviews findings and recommendations
of periodic and episodic grantee
assessments, developing actions needed
to assure continuity of services to
underserved and vulnerable populations
and appropriate use of Federal
resources; (7) identifies, provides and
coordinates training and technical
assistance activities for BPHC primary
health care grant programs, including
State-based training and technical
assistance; (8) conducts State and
regional surveillance on issues that
affect BPHC grant programs; and (9)
provides consultation to and
coordinates activities within HRSA and
HHS, and with other Federal agencies,
State and local governments, and other
public and private organizations
involved in the implementation of
program activities.
Western Division (RCQ)
Manages BPHC primary health care
grant programs and activities within
HHS Regions 7, 8, 9 and 10.
Specifically, for regions 7, 8, 9 and 10:
(1) Manages the post-award
administration of the Bureau’s primary
health care grant programs; (2) serves as
the BPHC representative to
organizations receiving Bureau grants;
(3) promotes a continued focus on
efficient and effective care for
underserved and vulnerable
populations; (4) communicates and
interprets program statutory/regulatory
requirements, policy, expectations and
reporting requirements, providing
technical guidance to grantees on the
management and integration of
community-based systems of care, the
VerDate Aug<31>2005
15:37 Nov 28, 2006
Jkt 211001
adaptation of successful strategies/
models, and the resolution of difficult
issues; (5) monitors the performance of
BPHC primary health care grantees,
making programmatic recommendations
and providing assistance to improve
performance, where appropriate; (6)
reviews findings and recommendations
of periodic and episodic grantee
assessments, developing actions needed
to assure continuity of services to
underserved and vulnerable populations
and appropriate use of Federal
resources; (7) identifies, provides and
coordinates training and technical
assistance activities for BPHC primary
health care grant programs, including
State-based training and technical
assistance; (8) conducts State and
regional surveillance on issues that
affect BPHC grant programs; and (9)
provides consultation to and
coordinates activities within HRSA and
HHS, and with other Federal agencies,
State and local governments, and other
public and private organizations
involved in the implementation of
program activities.
Section RC–30, Delegations of Authority
All delegations of authority and redelegations of authority made to HRSA
officials that were in effect immediately
prior to this reorganization, and that are
consistent with this reorganization,
shall continue in effect pending further
re-delegation.
This reorganization is effective upon
the date of signature.
November 7, 2006.
Elizabeth M. Duke,
Administrator.
[FR Doc. E6–20171 Filed 11–28–06; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Amended Notice of Meeting
Notice is hereby given of a change in
the meeting of the National Heart, Lung,
and Blood Institute Special Emphasis
Panel, December 12, 2006, 2 p.m. to
December 12, 2006, 5 p.m., National
Institutes of Health, 6701 Rockledge
Drive, Bethesda, MD 20892 which was
published in the Federal Register on
November 3, 2006, FR–06–9030.
The December 12, 2006 meeting date
was changed to December 11, 2006. The
meeting is closed to the public.
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
69137
Dated: November 21, 2006.
David Clary,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–9457 Filed 11–28–06; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Health, Lung, and Blood
Institute; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
Childhood Asthma Follow-up Study.
Date: November 28, 2006.
Time: 10 a.m. to 1 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
(Telephone Conference Call).
Contact Person: Valerie L. Prenger, PhD,
Health Scientist Administrator, Division of
Extramural Affairs, National Heart, Lung, and
Blood Institute, 6701 Rockledge Drive, MSC
7924, Room 7214, Bethesda, MD 20892–7924.
(301) 435–0270. prengerv@nhlbi.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resource Research, National Institute of
Health, HHS)
Dated: November 21, 2006.
David Clary,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–9458 Filed 11–28–06; 8:45 am]
BILLING CODE 4140–01–M
E:\FR\FM\29NON1.SGM
29NON1
]]>Agencies
[Federal Register Volume 71, Number 229 (Wednesday, November 29, 2006)]
[Notices]
[Page 69137]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 06-9457]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood Institute; Amended Notice of
Meeting
Notice is hereby given of a change in the meeting of the National
Heart, Lung, and Blood Institute Special Emphasis Panel, December 12,
2006, 2 p.m. to December 12, 2006, 5 p.m., National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD 20892 which was published in
the Federal Register on November 3, 2006, FR-06-9030.
The December 12, 2006 meeting date was changed to December 11,
2006. The meeting is closed to the public.
Dated: November 21, 2006.
David Clary,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 06-9457 Filed 11-28-06; 8:45 am]
BILLING CODE 4140-01-M
